Motus GI Holdings announces use of FDA cleared Pure-Vu EVS Gastro

Motus GI Holdings announced that the Pure-Vu EVS Gastro was used in the first procedure since receiving FDA clearance. The case was completed by Dr. Brian Hanson, Gastroenterologist and Associate Professor of Medicine, University of Minnesota. “We appreciate Dr. Hanson and his team coordinating this first procedure with the Motus team as we bring on this new offering with the Pure-Vu EVS Gastro, along with our latest generation of the colon device,” commented Mark Pomeranz, Chief Executive Officer. “It is exciting to clear the first procedure milestone so soon after receiving FDA clearance. We look to forward to implementing the planned U.S. market introduction of the Pure-Vu EVS Gastro. Currently, our team is working hard to allow us to place this new device and our next generation colon product in top hospital systems in order to establish a foundation of reference centers to support our strategic initiatives.”